Logo.jpg
Dexamethasone Market To Reach USD 1393.0 Billion By 2032 Report By DataHorizzon Research
October 17, 2023 08:00 ET | DataHorizzon Research
Fort Collins, Colorado, Oct. 17, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, the dexamethasone market size was valued at USD 754.1 Million in 2022 to reach USD 1393.0 Million by...
multiple-myeloma-market-size.jpg
Global Multiple Myeloma Market Report 2023: Sector is Expected to Reach $37.5 Billion by 2029 at a CAGR of 9.8%
June 08, 2023 11:38 ET | Research and Markets
Dublin, June 08, 2023 (GLOBE NEWSWIRE) -- The "Global Multiple Myeloma Market Size, Share & Industry Trends Analysis Report By End User, By Disease Type (Active Multiple Myeloma and Smoldering...
Future Market Insights.png
Retinal Vein Occlusion Treatment Market to reach US$ 2.3 billion in 2023 -end, expected to grow at a 5.9% CAGR until 2033: Future Market Insights, Inc. NEWARK, Del, March 21, 2023 (GLOBE NEWSWIRE) -- The global retinal vein occlusion treatment market is likely to register a CAGR of 5.9% from 2023 to 2033. According to Future Market Insights, a...
22157.jpg
Global Multiple Myeloma Drugs Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
August 25, 2021 08:38 ET | Research and Markets
Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
22157.jpg
Global Corticosteroids Market Report 2021 Featuring Major Players - Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca, Cipla, and LEO Pharma
May 13, 2021 04:53 ET | Research and Markets
Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Corticosteroids Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering. Major...
Picture1.jpg
Oncotelic Joins Chopra Foundation and Heart Foundation of India to Provide Relief for India's Explosive 2nd Wave of Covid.
May 04, 2021 07:00 ET | Oncotelic Therapeutics, Inc.
AGOURA HILLS, California, May 04, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic"), a leading developer of TGF-β therapeutics for oncology and infectious disease and...
22157.jpg
Global Multiple Myeloma Disease Coverage Forecast and Market Analysis Report 2021: Comprehensive Collection of All Recent Events that has Affected the Market and Future Trends
April 12, 2021 06:58 ET | Research and Markets
Dublin, April 12, 2021 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Disease Coverage Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering. Multiple myeloma is...
22157.jpg
Worldwide Multiple Myeloma Drugs Industry to 2025 - Players Include Amgen, Bristol-Myers Squibb & Daiichi Sankyo
December 01, 2020 06:38 ET | Research and Markets
Dublin, Dec. 01, 2020 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
22157.jpg
Global Multiple Myeloma Disease Coverage Forecast and Market Analysis to 2027
October 09, 2020 04:44 ET | Research and Markets
Dublin, Oct. 09, 2020 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Disease Coverage Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering. Multiple myeloma is...
logo.jpg
Helsinn Group and Italfarmaco announce oral presentation of NEPA (netupitant and palonosetron) data at ESMO Virtual Congress 2020
September 18, 2020 03:00 ET | Helsinn Healthcare S.A.
Helsinn Group and Italfarmaco announce oral presentation of NEPA (netupitant and palonosetron) data at ESMO Virtual Congress 2020       -       A Phase 3 study concludes that a simplified regimen of...